^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
Yuanruida (inaticabtagene autoleucel)
i
Other names: CNCT19, CNCT 19, HY001, CNCT-19, inati-cel, HY 001, HY-001
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
CASI, Juventas Cell Therapy
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
